Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab
暂无分享，去创建一个
F. Saad | F. Montorsi | M. Gallucci | M. Graefen | A. Briganti | S. Shariat | P. Karakiewicz | F. Chun | Z. Tian | C. Terrone | F. Chierigo | C. Leonardo | A. Panunzio | G. Sorce | A. Antonelli | B. Hoeh | R. Flammia | L. Hohenhorst